Anti-Mouse CD11a (Clone FD441.8) – Purified in vivo PLATINUM™ Functional Grade

Anti-Mouse CD11a (Clone FD441.8) – Purified in vivo PLATINUM™ Functional Grade

Product No.: C603

[product_table name="All Top" skus="C303"]

- -
- -
Clone
FD441.8
Target
CD11a
Formats AvailableView All
Product Type
Monoclonal Antibody
Alternate Names
LFA-1α
Isotype
Rat IgG2b
Applications
FA
,
FC
,
N
,
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Mouse
Host Species
Rat
Recommended Isotype Controls
Recommended Dilution Buffer
Immunogen
Cloned CTL B18 cells
Product Concentration
≥ 5.0 mg/ml
Endotoxin Level
<0.5 EU/mg as determined by the LAL method
Purity
≥98% monomer by analytical SEC
>95% by SDS Page
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Pathogen Testing
To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM™ antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day 2-8°C
Applications and Recommended Usage?
Quality Tested by Leinco
FC The suggested concentration for this FD441.8 antibody for staining cells in flow cytometry is ≤ .25 μg per 106 cells in a 100 µl volume or 100 µl of whole blood. Titration of the reagent is recommended for optimal performance for each application.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Clone FD441.8 recognizes an epitope on mouse CD11a.
Background
LFA-1α (CD11a) and CD18 are the Integrin alpha-L and beta-2 chains respectively that combine to form LFA-1, a glycoprotein and a member of the Integrin family. Integrin alpha-L/beta-2 is a receptor for ICAM1, ICAM2, ICAM3, ICAM4 and for F11R. LFA-1 participates in the immunological synapses between CD8+ T lymphocytes and antigen-presenting cells. The absence of LFA-1α or ß may induce LAD. The antigen contributes to natural killer cell cytotoxicity, and is involved in various immune phenomena such as leukocyte-endothelial cell interaction, cytotoxic T-cell mediated killing, and antibody dependent killing by granulocytes and monocytes. The CD11b/CD18 antigen is a heterodimeric surface glycoprotein on leukocytes and belongs to the ß2 integrin family. CD11b functions as a receptor for C3bi complement, clotting factor X, fibrinogen and ICAM-1. CD11c forms an α/ß heterodimeric glycoprotein (CD11c/CD18 complex) which belongs to the ß2 integrin family. The complex binds fibrinogen and reportedly serves as a receptor for iC3b and ICAM-1. During inflammatory responses, it mediates cell to cell interaction and is important in both monocyte adhesion and chemotaxis.
Antigen Distribution
CD11a is present on thymocytes, blood lymphocytes, bone marrow cells and certain lymphoma and macrophage-like cell lines.
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), and ICAM-3 (CD50)
Function
LFA-1 plays a central role in leukocyte intercellular adhesion.
PubMed
NCBI Gene Bank ID
Research Area
Cell Adhesion
.
Cell Biology
.
Costimulatory Molecules
.
Immunology
.
Signal Transduction

Leinco Antibody Advisor

Powered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments.

Clone FD441.8 is an anti-mouse CD11a (LFA-1?) monoclonal antibody that is widely used in in vivo mouse studies for functional modulation of the LFA-1 integrin, particularly in immune system research. Its primary applications are:

  • In vivo blockade (neutralization) of LFA-1 function: FD441.8 is frequently used to disrupt the interaction between LFA-1 and its ligands (ICAM-1/2/3) on leukocytes, which interferes with leukocyte adhesion, migration, and related immunological responses.
  • Leukocyte trafficking and immune cell migration studies: By blocking LFA-1, researchers assess the role of this integrin in processes such as T cell and leukocyte adhesion to endothelium and migration into tissues during inflammation or immune reactions.
  • Functional assays in autoimmunity, infection, transplant, and inflammation models: FD441.8 helps elucidate the importance of lymphocyte function–associated antigen-1 (LFA-1) in various pathophysiological contexts relevant to immune cell-mediated diseases.

Key technical details:

  • Isotype: Rat IgG2b.
  • Reported use: Neutralization/blockade in vivo, flow cytometry (FC), functional assays (FA), and sometimes in vitro studies.
  • Formulation: Typically provided in PBS with ultra-low endotoxin certification for in vivo use.
  • Storage: Generally stored at 4°C; do not freeze.

Example applications:

  • Injected into mice to temporarily block LFA-1 and assess consequent effects on immune cell distribution, tissue infiltration, or disease outcomes.
  • Used alongside isotype controls to confirm specificity of effects.

Summary: FD441.8 is a well-validated tool for transiently inhibiting CD11a (LFA-1) function in vivo in mice, supporting studies of leukocyte biology, immune trafficking, and disease mechanisms involving integrins.

If a specific experimental context or protocol is needed, please specify the area of research or disease model of interest.

The correct storage temperature for sterile packaged clone FD441.8 (HyClone™ FetalClone™ I serum) is ?10?°C or lower for long-term storage. Once thawed, the product should be stored at 2?°C to 8?°C. This temperature range maintains sterility and product quality.

  • Long-term storage: Store at ?10?°C or lower.
  • After thawing: Store at 2?°C to 8?°C, typically not longer than six weeks if opened.
  • If storage is needed beyond six weeks post-opening, aliquot and refreeze.

These recommendations are consistent with manufacturer guidance for HyClone FetalClone I and other similar serum products.

Commonly used antibodies or proteins studied alongside FD441.8 (anti-mouse CD11a/LFA-1?) in the literature focus on cell surface molecules or adhesion complexes that interact with or complement the role of LFA-1 in immune functions.

Key examples include:

  • CD18 (integrin ?2): CD11a (recognized by FD441.8) pairs with CD18 to form the functional LFA-1 heterodimer. Experimental setups involving FD441.8 may also include antibodies against CD18 to assess the full LFA-1 complex or compare blocking effects.

  • ICAM-1 (CD54), ICAM-2 (CD102), and ICAM-3 (CD50): These are the key ligands for LFA-1. Antibodies or labeled proteins directed against these intercellular adhesion molecules are often used in parallel to study binding, cell adhesion, or blocking interactions involving LFA-1.

  • Isotype controls (Rat IgG2b): Experimental controls using the same isotype as FD441.8 (Rat IgG2b, ?) are standard for precise gating and signal validation, such as FITC Rat IgG2b, ? Isotype Control[LTF-2].

  • Other leukocyte markers and functional antibodies: Depending on the specific immune cell subset targeted, combinations might include anti-CD3 (T cells), anti-CD4, anti-CD8, anti-CD45 (leukocytes), or cytokine-blocking antibodies. These help to delineate cell populations or parse signaling pathways in conjunction with LFA-1 activity.

In summary, the most commonly paired antibodies with FD441.8 target CD18, ICAM family members, and relevant isotype controls. Additional markers depend on the experimental focus but generally reflect the context in which LFA-1/CD11a function is being explored, such as T-cell activation, leukocyte adhesion, or immune cell migration.

Clone FD441.8 in scientific literature refers to a monoclonal antibody directed against mouse CD11a (LFA-1?), commonly used for immunological research, particularly in blocking studies and cell labeling. The key findings supported by clone FD441.8 citations include:

  • CD11a (LFA-1?) Targeting: FD441.8 is a rat-produced monoclonal antibody of isotype IgG2b that recognizes CD11a expressed on mouse thymocytes, blood lymphocytes, bone marrow cells, and certain lymphoma and macrophage-like cell lines.
  • Functional Blocking: This clone is frequently utilized in experiments to block LFA-1 function, which is crucial for cell adhesion, migration, and immunological synapse formation between lymphocytes and antigen-presenting cells.
  • Applications: Typical research applications for FD441.8 include blocking assays (inhibiting LFA-1-dependent interactions), immunohistochemistry (IHC), immunoprecipitation (IP), and in situ hybridization (ISH).
  • Adoptive Immunotherapy Studies: FD441.8 has been instrumental in studies involving antibody-mediated B-cell depletion prior to adoptive immunotherapy. It is often referenced in protocols involving flow cytometry to analyze the effects of LFA-1 blockade on immune cell interactions, transplant rejection, and immune modulation.

No direct findings specific to FD441.8 about clone-initiating cell (CIC) tracking or metastatic studies are reported in the citations provided. Its main impact in the literature is its role as a tool for functional inhibition and cell labeling in mouse immunology.

References & Citations

1. Suratt, Benjamin T. et al. (2009) J Immunol.182(1): 604–612. PubMed
2. Wuthrich, R. P. et al. (1991) Cell Immunol. 144:22
3. Sanchez-Madrid, F. et al. (1983) J. Exp. Med. 158(20):586
4. Pont, S. et al. (1986) J. Immunol. 136(10):3750
FA
Flow Cytometry
N
General Western Blot Protocol

Certificate of Analysis

- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.